Placed on Senate Legislative Calendar under General Orders. Calendar No. 293.
This joint resolution, filed under the Congressional Review Act (5 U.S.C. chapter 8), states that Congress disapproves the Centers for Medicare & Medicaid Services (CMS) rule titled "Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability" (90 Fed.
Reg. 27074 (June 25, 2025)) and declares that the rule "shall have no force or effect." The resolution was introduced in the Senate and referred to the Committee on Health, Education, Labor, and Pensions; committee discharge is noted in the bill text.
Under the statute cited (the CRA), a successful resolution would nullify the specified CMS rule and carry the CRA consequence that the agency generally may not reissue a substantially similar rule without new statutory authorization from Congress.
On substance the bill is narrow and administratively simple, which makes it easier to advance procedurally than omnibus legislation. At the same time, it directly targets a politically salient area (ACA marketplace rules) with active stakeholders; it contains no compromise features and its success depends almost entirely on whether a majority in each chamber wishes to overturn the agency action and whether the executive branch would accept the disapproval. These dependencies create meaningful uncertainty and reduce overall likelihood.
Relative to its intended legislative type, this bill is concise and narrowly focused: it identifies and disapproves a specific CMS rule under the Congressional Review Act and states the immediate legal effect. It relies on the CRA statutory framework for procedural and substantive consequences rather than restating those provisions.
Whether using the Congressional Review Act here is an appropriate oversight tool versus an overbroad way to block technical agency fixes.
Whether using the Congressional Review Act here is an appropriate oversight tool versus an overbroad way to block technical agency fixes.
Given that the resolution explicitly nullifies a CMS rule titled to affect ACA marketplace integrity and affordability and that the sponsors are largely Democratic, a mainstream liberal/left-leaning observer would likely view the joint resolution as a necessary step to block a rule they see as harmful to consumers and to protections in the Affordable Care Act.
They would interpret the disapproval as protecting access, affordability, and consumer safeguards that the ACA provides.
They would also recognize the procedural seriousness of using the CRA but likely view it as appropriate if the rule undermined coverage or affordability.
A centrist or moderate would approach the resolution with caution: they would view the CRA as a legitimate oversight tool but would want to see the CMS rule's substantive text, regulatory analysis, and projected impacts before taking a firm position.
They would weigh the immediate effect of blocking the rule against the long-term effect of using the CRA to foreclose similar agency actions.
Without the underlying rule details, a centrist is likely to be mixed — open to disapproval if the rule demonstrably harms consumers or raises costs, but skeptical of sweeping CRA use without clear evidence.
A mainstream conservative would focus on preserving regulatory flexibility for CMS, reducing federal overreach, and promoting market-based integrity measures; absent the rule text, they would likely oppose a congressional disapproval resolution that uses the CRA to totally nullify agency action unless they believe the rule increased federal spending or interference.
However, because the resolution is sponsored by a large group of Democrats seeking to disapprove a CMS rule, a conservative may view the underlying rule as potentially favorable to their goals (e.g., tightening integrity or imposing limits on subsidies) and therefore oppose the joint resolution.
Overall, the conservative position will depend on whether they interpret the rule as expanding federal mandates or improving fraud control — the bill text alone leaves that unclear.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On substance the bill is narrow and administratively simple, which makes it easier to advance procedurally than omnibus legislation. At the same time, it directly targets a politically salient area (ACA marketplace rules) with active stakeholders; it contains no compromise features and its success depends almost entirely on whether a majority in each chamber wishes to overturn the agency action and whether the executive branch would accept the disapproval. These dependencies create meaningful uncertainty and reduce overall likelihood.
On the Motion to Proceed S.J.Res. 84
Whether using the Congressional Review Act here is an appropriate oversight tool versus an overbroad way to block technical agency fixes.
On substance the bill is narrow and administratively simple, which makes it easier to advance procedurally than omnibus legislation. At the…
Relative to its intended legislative type, this bill is concise and narrowly focused: it identifies and disapproves a specific CMS rule under the Congressional Review Act and states the immediate legal effect. It relies…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.